Puma Biotechnology, Inc. logo

PBYI

Puma Biotechnology, Inc.

$5.17

Earnings Summary

Revenue
$72.18Mn
Net Profits
$12.27Mn
Net Profit Margins
17%
PE Ratio
11.13

Highlights

Revenue:

Puma Biotechnology, Inc.’s revenue jumped 9.86% since last year same period to $72.18Mn in the Q4 2023. On a quarterly growth basis, Puma Biotechnology, Inc. has generated 28.62% jump in its revenue since last 3-months.

Net Profits:

Puma Biotechnology, Inc.’s net profit jumped 319.07% since last year same period to $12.27Mn in the Q4 2023. On a quarterly growth basis, Puma Biotechnology, Inc. has generated 111.66% jump in its net profits since last 3-months.

Net Profit Margins:

Puma Biotechnology, Inc.’s net profit margin jumped 299.41% since last year same period to 17% in the Q4 2023. On a quarterly growth basis, Puma Biotechnology, Inc. has generated 64.56% jump in its net profit margins since last 3-months.

PE Ratio:

Puma Biotechnology, Inc.’s price-to-earnings ratio after this Q4 2023 earnings stands at 11.13.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Puma Biotechnology, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-0.22
EPS Estimate Current Year
-0.22

Highlights

EPS Estimate Current Quarter:

Puma Biotechnology, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.22 - a -173.33% fall from last quarter’s estimates.

EPS Estimate Current Year:

Puma Biotechnology, Inc.’s earning per share (EPS) estimates for the current year stand at -0.22.

Key Ratios

Key ratios of the Puma Biotechnology, Inc. post its Q4 2023 earnings

Earning Per Share (EPS)
0.26
Return on Assets (ROA)
0.09
Return on Equity (ROE)
0.58

Highlights

Earning Per Share (EPS):

Puma Biotechnology, Inc.’s earning per share (EPS) jumped 316.67% since last year same period to 0.26 in the Q4 2023. This indicates that the Puma Biotechnology, Inc. has generated 316.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Puma Biotechnology, Inc.’s return on assets (ROA) stands at 0.09.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Puma Biotechnology, Inc.’s return on equity (ROE) stands at 0.58.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-02
0.08
0.12
50%
2024-02-29
0.3
0.26
-13.33%
2023-08-03
0.01
0.05
400%
2023-05-04
-0.07
0.03
142.86%